CYS Investments (CYS Investments) Change In Working Capital : $13.58 Mil (TTM As of Mar. 2018)

View and export this data going back to 2009. Start your Free Trial

What is CYS Investments Change In Working Capital?

CYS Investments's change in working capital for the quarter that ended in Mar. 2018 was $-2.17 Mil.

CYS Investments's change in working capital for the fiscal year that ended in Dec. 2017 was $10.60 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

CYS Investments Change In Working Capital Historical Data

The historical data trend for CYS Investments's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CYS Investments Change In Working Capital Chart

CYS Investments Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Change In Working Capital

Get a 7-Day Free Trial

9.58

2.00

7.57

-1.22

10.60

CYS Investments Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Change In Working Capital	Get a 7-Day Free Trial															-5.15	0.79	5.69	9.26	-2.17

CYS Investments Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.58 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

CYS Investments Change In Working Capital Related Terms

Thank you for viewing the detailed overview of CYS Investments's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CYS Investments (CYS Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » CYS Investments Inc (NYSE:CYS) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cysinv.com

CYS Investments Inc is a specialty finance company with the objective of risk-adjusted investment income. The company generates its revenue primarily from the difference between the interest income earned on the investment portfolio and the cost of the company's borrowings and hedging activities. The company's investments include residential mortgage pass-through securities, for which the principal and interest payments are guaranteed by a government agency or government-sponsored entity; collateralised mortgage obligations issued by a government agency or government-sponsored entity; U.S. Treasuries; and debt securities issued by a government agency or a government-sponsored entity that is not backed by collateral.

Executives

Redlingshafer Raymond A Jr	director	1301 AVENUE OF THE AMERICAS, 7TH FLOOR, NEW YORK NY 10019
Dale Anne Reiss	director	589 KINZIE ISLAND COURT, SANIBEL FL 33957
James A Stern	director	C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Kevin E Grant	director, officer: Chairman, CEO, CIO, President	500 TOTTEN POND ROAD, 6TH FLOOR, WALTHAM MA 02451
Thomas A Rosenbloom	officer: EVP, GC, and Secretary	500 TOTTEN POND ROAD, 6TH FLOOR, WALTHAM MA 02451
Richard E Cleary	officer: COO and Assistant Secretary	500 TOTTEN POND ROAD, 6TH FLOOR, WALTHAM MA 02451
Tanya S Beder	director	500 TOTTEN POND ROAD, 6TH FLOOR, WALTHAM MA 02451
Jack Decicco	officer: CFO and Treasurer	500 TOTTEN POND ROAD, 6TH FLOOR, WALTHAM MA 02451
Karen Hammond	director	1601 UTICA AVENUE SOUTH, SUITE 900, ST. LOUIS PARK MN 55416
Stephen P. Jonas	director	25 BEAVER PLACE, BOSTON MA 02108
David A Tyson	director	CITIGROUP ASSET MANAGEMENT, 300 FIRST STAMFORD PLACE 4TH FL, STAMFORD CT 06902
Jeffrey Hughes	director	811 HANSEN WAY, PALO ALTO CA 94303
Frances Spark	officer: CFO and Treasurer	C/O AGNC INVESTMENT CORP., 2 BETHESDA METRO CENTER, 12TH FLOOR, BETHESDA MD 20814
Douglas Ii Crocker	director	C/O COLONY NORTHSTAR, INC., 515 S. FLOWER ST., 44TH FLOOR, LOS ANGELES CA 90071
Ryan Randall Brenneman	officer: Chief Accounting Officer	C/O EYEGATE PHARMACEUTICALS, INC., 271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM MA 02452